Piper Jaffray Cuts Price Target on Marine Bio (MBII) Following 1Q Report
Piper Jaffray maintained an Overweight rating on Marrone Bio Innovations (NASDAQ: MBII), and cut the price target to $1.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
